# Clinical Study for the Effectiveness of Roflumilast Treatment in COPD Greek Patients Based on Standard Clinical Practice.

> **NCT05426915** · — · UNKNOWN · sponsor: **Elpen Pharmaceutical Co. Inc.** · enrollment: 750 (estimated)

## Conditions studied

- Copd
- COPD Exacerbation

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05426915
- **Lead sponsor:** Elpen Pharmaceutical Co. Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-05-01
- **Primary completion:** 2024-05-01
- **Final completion:** 2024-05-01
- **Target enrollment:** 750 (ESTIMATED)
- **Last updated:** 2023-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05426915

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05426915, "Clinical Study for the Effectiveness of Roflumilast Treatment in COPD Greek Patients Based on Standard Clinical Practice.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05426915. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*